Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Is body composition an important variable in the pharmacokinetics of anticancer drugs? A review and suggestions for further research.

Literature DB >> 8174199

Is body composition an important variable in the pharmacokinetics of anticancer drugs? A review and suggestions for further research.

J J Reilly¹, P Workman.

Abstract

Mesh：

Substances：
Antineoplastic Agents

Year: 1994 PMID： 8174199 DOI： 10.1007/bf00686105

Source DB: PubMed Journal: Cancer Chemother Pharmacol ISSN： 0344-5704 Impact factor: 3.333

× No keyword cloud information.

42 in total

1. Pharmacologically based dosing of etoposide: a means of safely increasing dose intensity.

Authors: M J Ratain; R Mick; R L Schilsky; N J Vogelzang; F Berezin
Journal: J Clin Oncol Date: 1991-08 Impact factor: 44.544

2. Body composition measurements for nutrition research.

Authors: W A Coward; S A Parkinson; P R Murgatroyd
Journal: Nutr Res Rev Date: 1988-01 Impact factor: 7.800

3. Is dose normalization to weight or body surface area useful in adults?

Authors: L B Grochow; C Baraldi; D Noe
Journal: J Natl Cancer Inst Date: 1990-02-21 Impact factor: 13.506

4. Reappraisal of some dosage adjustment guidelines.

Authors: A Sulkes; J M Collins
Journal: Cancer Treat Rep Date: 1987-03

5. Statistical methods for assessing agreement between two methods of clinical measurement.

Authors: J M Bland; D G Altman
Journal: Lancet Date: 1986-02-08 Impact factor: 79.321

6. Gross tissue weights in the human body by cadaver dissection.

Authors: J P Clarys; A D Martin; D T Drinkwater
Journal: Hum Biol Date: 1984-09 Impact factor: 0.553

7. Comparison of methods of estimating body fat in normal subjects and cancer patients.

Authors: S H Cohn; K J Ellis; D Vartsky; A Sawitsky; W Gartenhaus; S Yasumura; A N Vaswani
Journal: Am J Clin Nutr Date: 1981-12 Impact factor: 7.045

8. Effect of body weight on the pharmacokinetics of cyclophosphamide in breast cancer patients.

Authors: G Powis; P Reece; D L Ahmann; J N Ingle
Journal: Cancer Chemother Pharmacol Date: 1987 Impact factor: 3.333

Review 9. Population pharmacokinetics. Theory and clinical application.

Authors: B Whiting; A W Kelman; J Grevel
Journal: Clin Pharmacokinet Date: 1986 Sep-Oct Impact factor: 6.447

10. Prednisolone disposition in obese men.

Authors: R L Milsap; K I Plaisance; W J Jusko
Journal: Clin Pharmacol Ther Date: 1984-12 Impact factor: 6.875

7 in total

1. Malnutrition as a prognosis factor in lymphoblastic leukemia: a multivariate analysis.

Authors: J J Reilly; I Odame; B E Gibson; B A Wharton
Journal: Arch Dis Child Date: 1995-01 Impact factor: 3.791

Review 2. Risk factors determining chemotherapeutic toxicity in patients with advanced colorectal cancer.

Authors: F G Jansman; D T Sleijfer; J L Coenen; J C De Graaf; J R Brouwers
Journal: Drug Saf Date: 2000-10 Impact factor: 5.606

Review 3. Practical treatment guide for dose individualisation in cancer chemotherapy.

Authors: P Canal; E Chatelut; S Guichard
Journal: Drugs Date: 1998-12 Impact factor: 9.546

4. Muscle mass at the time of diagnosis of nonmetastatic colon cancer and early discontinuation of chemotherapy, delays, and dose reductions on adjuvant FOLFOX: The C-SCANS study.

Authors: Elizabeth M Cespedes Feliciano; Valerie S Lee; Carla M Prado; Jeffrey A Meyerhardt; Stacey Alexeeff; Candyce H Kroenke; Jingjie Xiao; Adrienne L Castillo; Bette J Caan
Journal: Cancer Date: 2017-09-07 Impact factor: 6.860